BioMarin Pharmaceutical
BMRN
#1020
Rank
$15.45 B
Marketcap
$83.52
Share price
0.44%
Change (1 day)
-1.08%
Change (1 year)

Market capitalization of BioMarin Pharmaceutical (BMRN)

Market cap: $15.45 Billion

As of June 2022 BioMarin Pharmaceutical has a market cap of $15.45 Billion. This makes BioMarin Pharmaceutical the world's 1020th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioMarin Pharmaceutical from 2001 to 2022

Year Market cap Change
2022$16.06 B-0.95%
2021$16.22 B1.9%
2020$15.91 B4.69%
2019$15.20 B0.18%
2018$15.17 B-3.08%
2017$15.66 B9.92%
2016$14.24 B-15.8%
2015$16.92 B25.55%
2014$13.47 B33.54%
2013$10.09 B63.05%
2012$6.18 B57.63%
2011$3.92 B31.8%
2010$2.97 B56.88%
2009$1.89 B6.88%
2008$1.77 B-48.31%
2007$3.43 B128.67%
2006$1.50 B87.69%
2005$0.80 B94.33%
2004$0.41 B-17.21%
2003$0.49 B31.3%
2002$0.37 B-46.16%
2001$0.70 B

End of Day market cap according to different sources

On Jun 28th, 2022 the market cap of BioMarin Pharmaceutical was reported to be:

$15.26 Billion
by Yahoo Finance
$15.38 Billion
by CompaniesMarketCap
$15.38 Billion
by Nasdaq
$15.39 Billion
by Iex Cloud

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
$132.89 B 760.12%๐Ÿ‡ซ๐Ÿ‡ท France
$4.15 B-73.10%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.60 B-96.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.41 B-97.34%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.98 B-80.65%๐Ÿ‡บ๐Ÿ‡ธ USA